Investors

Medibiofarma’s has closed two financing rounds supported by the founders.

PUBLIC FUNDS

This company has received a grant co-financed 50% by the European Regional Development Fund through the Operative Program FEDER 2014-2020 of Navarra, for the project:“Discovery of new PPAR-gamma antagonists for the treatment of bladder cancer” (0011-1365-2018-000110)

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the mentioned cookies and the acceptance of our Cookies policy.
. ACEPTAR

Aviso de cookies